Overes, Maribel A.

HRN: 21-00-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
MEBENDAZOLE 500MG (TAB)
05/25/2022
06/01/2022
ORAL
500mg
Q8
S/P LTCS ; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Choice 

Overall appropriateness: No  Wrong Choice

Intervention



Type of Intervention done:

                    

           


Acceptance: